Chemical biology and pharmacology of histone lysine methylation inhibitors

SH Barghout, RAC Machado… - Biochimica et Biophysica …, 2022 - Elsevier
Histone lysine methylation is a post-translational modification that plays a key role in the
epigenetic regulation of a broad spectrum of biological processes. Moreover, the …

PRDM16 regulating adipocyte transformation and thermogenesis: a promising therapeutic target for obesity and diabetes

N Jiang, M Yang, Y Han, H Zhao, L Sun - Frontiers in pharmacology, 2022 - frontiersin.org
Given that obesity and diabetes have been major public health concerns and that disease
morbidities have been rising continuously, effective treatment for these diseases is urgently …

The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression

N Liu, J Zhang, W Chen, W Ma, T Wu - Journal of Experimental & Clinical …, 2023 - Springer
Abstract Background RNA N6-Methyladenosine (m6A) modification is implicated in the
progression of human cancers including cholangiocarcinoma (CCA). METTL16 is recently …

Understanding the molecular basis of cardiomyopathy

ML Bang, J Bogomolovas… - American Journal of …, 2022 - journals.physiology.org
Inherited cardiomyopathies are a major cause of mortality and morbidity worldwide and can
be caused by mutations in a wide range of proteins located in different cellular …

[HTML][HTML] Updated understanding of the protein–DNA recognition code used by C2H2 zinc finger proteins

X Zhang, RM Blumenthal, X Cheng - Current Opinion in Structural Biology, 2024 - Elsevier
Abstract C2H2 zinc-finger (ZF) proteins form the largest family of DNA-binding transcription
factors coded by mammalian genomes. In a typical DNA-binding ZF module, there are …

RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer

M Di Donato, E Di Zazzo, A Salvati… - Journal of Translational …, 2023 - Springer
Background Colorectal cancer (CRC) is the third most deadly and fourth most diagnosed
cancer worldwide. Despite the progress in early diagnosis and advanced therapeutic …

PRDM10 directs FLCN expression in a novel disorder overlapping with Birt–Hogg–Dubé syndrome and familial lipomatosis

I van de Beek, IE Glykofridis… - Human Molecular …, 2023 - academic.oup.com
Abstract Birt–Hogg–Dubé syndrome (BHD) is an autosomal dominant disorder
characterized by fibrofolliculomas, pulmonary cysts, pneumothoraces and renal cell …

PRDM12 in health and diseases

M Rienzo, E Di Zazzo, A Casamassimi… - International Journal of …, 2021 - mdpi.com
PRDM12 is a member of the PRDI-BF1 (positive regulatory domain I-binding factor 1)
homologous domain (PRDM)-containing protein family, a subfamily of Kruppel-like zinc …

Cancer epigenetics: promises and pitfalls for cancer therapy

E Skourti, P Dhillon - The FEBS Journal, 2022 - Wiley Online Library
Over the past few decades, epigenetic regulators have emerged as major players in cellular
processes that drive cancer initiation and progression, and subsequently modulate the …

[HTML][HTML] Prdm6 drives ductus arteriosus closure by promoting ductus arteriosus smooth muscle cell identity and contractility

M Zou, KD Mangum, JC Magin, HH Cao, MT Yarboro… - JCI insight, 2023 - ncbi.nlm.nih.gov
Based upon our demonstration that the smooth muscle cell–selective (SMC-selective)
putative methyltransferase, Prdm6, interacts with myocardin-related transcription factor-A …